6''-O-carbamoyltobramycin(51736-77-7)
- Name: 6''-O-carbamoyltobramycin
- Synonyms:6''-O-Carbamoyltobramycin;Nebramycin V'; Nebramycin factor 5'; Tobramycin carbamate
- Molecular Formula:C19H38 N6 O10
- Molecular Weight:510.54
- CAS Registry Number:51736-77-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.51736-77-7 6''-O-carbamoyltobramycin
Assay:99% Package:According to customer requirements Transportation:By Sea/Air/Courier Application:medicine
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.51736-77-7 6''-O-carbamoyltobramycin
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.51736-77-7 6''-O-carbamoyltobramycin
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:6''-O-carbamoyltobramycin
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.51736-77-7 Tobramycin Carbamate
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.51736-77-7 6''-O-Carbamoyltobramycin
Assay:>96% Appearance:White Amorphous Powder Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 701-30-4/1-tert-Butyl-4-fluorobenzene
- 4572-09-2/Allantoin glycyrrhetinic acid
- 84435-01-8/1,1,1-(1,1,3-Trimethyl-5-methylenepentane-1,3,5-triyl)tribenzene
- 52831-58-0/4-FLUORO-6H-(1)BENZOTHIOPYRANO(4,3-b)QUINOLINE
- 571-60-8/1,4-Dihydroxynaphthalene
- 125304-12-3/1,3-Benzenedicarboxylic acid, polymer with 1-amino-2-propanol and 1,4-cyclohexanedimethanol
- 25966-79-4/[1aS-(1aalpha,2alpha,4abeta,8aR*)]-octahydro-2,4a,8,8-tetramethylcyclopropa[d]naphthalen-3(1H)-one
- 25274-95-7/5,10-Ethano-1H-[1,2,4]triazolo[1,2-a][1,2]diazocine-1,3(2H)-dione,hexahydro-
- 91062-54-3/5-(2-bromoprop-2-en-1-yl)-5-propylpyrimidine-2,4,6(1H,3H,5H)-trione
- 33531-59-8/2-Methylphenylcarbamic acid 1-ethyl-3-piperidyl ester
- 670-24-6/(S)-1,2,3,4,5,6,7,8-octahydro-2,5,5-trimethyl-2-naphthol
- 83546-42-3/2'-Fluoro-5-ethylarabinosyluracil
- 63951-35-9/N,N,N-trimethyl-5-[(methylcarbamoyl)oxy]-1,2,3,4-tetrahydronaphthalen-1-aminium iodide
- 5878-47-7/N-(2,3-dimethylquinoxalin-6-yl)-2-phenylhydrazinecarbothioamide
- 294-90-6/Cyclen
- 18268-70-7/3,6,9-Trioxaundecamethylene bis(2-ethylhexanoate)
- 84946-21-4/N-(2-chloroethyl)-2-nitrobenzamide
- 6252-78-4/sodium 2-[3-(4-sulfonato-o-tolyliminio)-6-o-toluidino-3H-xanthen-9-yl]benzoate
- 8040-17-3/(C6-C12)Alkylcarboxylic acid
- 51736-77-7/6''-O-carbamoyltobramycin
- 63731-91-9/2-phenyl-1-(pyridin-2-ylamino)ethanol hydrochloride (1:1)
- 79660-71-2/N-demethylfleroxacin
- 10243-48-8/Imidodicarbonimidicdiamide, N-cyclopentyl-, hydrochloride (1:1)
- 91887-42-2/2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylic acid, 11-((2,6-dideoxy-3-O-methyl-alpha-L-lyxo-hexopyranosyl)oxy)-5-((2,6-dideoxy-4-O-(2,3,6-trideoxy-3-C-methyl-3-nitro-beta-L-ribo-hexopyranosyl)-alpha-L-lyxo-hexopyranosyl)oxy)-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,8,10,13-tetrahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, (2R-(2-alpha,3-beta,4-alpha,5-alpha,6-alpha,11-beta,13-alpha,14-alpha))-
- 6128-52-5/2-chloro-N,N-bis[4-(N,N-dimethylcarbamimidoyl)-3-methoxy-phenyl]benzene-1,4-dicarboxamide
- 63667-16-3/Dribendazole
- 26761-64-8/1H-Benzimidazoledisulfonicacid, 2-heptadecyl-, sodium salt (1:2)
- 19581-16-9/ethyl 4-{(E)-[2,4-diamino-6-({6-[(2-chloroethyl)(ethyl)amino]hexyl}amino)pyrimidin-5-yl]diazenyl}benzoate hydrochloride (1:1)
- 23474-69-3/2-[2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)ethyl]guanidine sulfate (2:1)
- 84604-42-2/1,3-benzodioxol-5-ylmethyl isovalerate